MCM
AZN icon

MAI Capital Management’s AstraZeneca AZN Stock Holding History

MAI Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.13M Buy
16,531
+3,671
+29% +$690K 0.01% 572
2026
Q1 		$2.54M Buy
12,860
+2,764
+27% +$533K 0.01% 533
2025
Q4 		$1.86M Sell
10,096
-82
-0.8% -$14.4K 0.01% 577
2025
Q3 		$1.56M Sell
10,178
-1,129
-10% -$171K 0.01% 596
2025
Q2 		$1.58M Buy
11,307
+1,224
+12% +$172K 0.01% 547
2025
Q1 		$1.48M Sell
10,083
-520
-5% -$75.2K 0.01% 539
2024
Q4 		$1.39M Buy
10,603
+3,825
+56% +$536K 0.01% 553
2024
Q3 		$1.06M Sell
6,778
-2,763
-29% -$446K 0.01% 546
2024
Q2 		$1.49M Buy
9,541
+1,088
+13% +$164K 0.01% 483
2024
Q1 		$1.15M Sell
8,453
-148
-2% -$19.6K 0.01% 534
2023
Q4 		$1.16M Buy
8,601
+112
+1% +$14.6K 0.02% 434
2023
Q3 		$1.15M Sell
8,489
-132
-2% -$18K 0.02% 402
2023
Q2 		$1.23M Sell
8,621
-2,707
-24% -$398K 0.02% 393
2023
Q1 		$1.57M Sell
11,328
-592
-5% -$79.6K 0.02% 343
2022
Q4 		$1.62M Buy
11,920
+4,225
+55% +$530K 0.03% 326
2022
Q3 		$844K Buy
7,695
+4,383
+132% +$556K 0.02% 416
2022
Q2 		$438K Sell
3,312
-201
-6% -$26.4K 0.01% 578
2022
Q1 		$466K Buy
3,513
+618
+21% +$74.1K 0.01% 582
2021
Q4 		$337K Sell
2,895
-439
-13% -$51.7K 0.01% 670
2021
Q3 		$400K Buy
3,334
+1,096
+49% +$128K 0.01% 561
2021
Q2 		$268K Buy
+2,238
New +$246K 0.01% 629

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MAI Capital Management's AZN Position: Q2 2026 in Review

MAI Capital Management increased its AstraZeneca (AZN) stake by 29% in Q2 2026, buying an estimated $690K and bringing the position to 16,531 shares worth $3.13M. The position accounts for 0.01% of the portfolio, ranked #572.

MAI Capital Management first reported a position in AZN in Q2 2021 and has held it in 21 quarters since. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • MAI Capital Management held 16,531 shares of AstraZeneca worth $3.13M as of Q2 2026.
  • MAI Capital Management bought 3,671 AstraZeneca shares in Q2 2026, an estimated $690K.
  • AstraZeneca made up 0.01% of MAI Capital Management's portfolio in Q2 2026, its #572 holding.
  • MAI Capital Management first reported a position in AstraZeneca in Q2 2021 and has held it in 21 quarters since.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.